Burguet LN, Trimiño RJA

Language: Spanish
References: 26
Page: 278-285
PDF size: 129.17 Kb.

ABSTRACT

Staff is the main cause of contamination in aseptic drug production process, due to microorganism and non viable particles. The goal of this paper is to isolate staphylococcus aureus strain from the staff working in clean rooms. Nasopharyngeal swabs were performed on this staff. 50 strains were isolated. Six were sthaphylococcus aureus, (12 %). Other microorganisms were isolated which are considered pathogen germens since they are located in the area. Results express how important personnel monitoring is as parts of the Environmental Monitoring Program in the Pharmaceutical Industry, mainly in aseptic process.

REFERENCES

1. Weber JT. Community-associated methicillin -resistant Staphylococcus aureus. Clin Infect Dis. 2005;41(4)269-72.

2. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279(8):593-8.

3. Pate K, Bannerman T, Feldman S. Methicillin-resistant Staphylococcus aureus in the community. Lancet. 1995;346(8968):132-5.

4. Naimi TS, LeDell KH, Como-Sabetti K. Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):2976-84.

5. Salmenlinna S, Lyytikäinen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis. 2002;8(6):602-7.

6. Shuhaibar MN, Falkiner FR. The prevalence, antibiotic susceptibility and phage-type of nasal carried Staphylococcus aureus in the Dublin community. J Med Sci 1992;161(10):589-92.

7. Zanelli G, Sansoni A, Zanchi A, Cresti S, Pollini S, Rossolini GM. Staphylococcus aureus nasal carriage in the community: A survey from central Italy. Epidemiol Infect. 2002;129(2):417-20.

8. Abudu L, Blair I, Fraise A, Cheng KK. Methicillin-resistant Staphylococcus aureus (MRSA): A community-based prevalence survey. Epidemiol Infect. 2001;126(3):351-6.

9. Otaolea L, Eiros JM, Ortiz de Lejarazu R, Carrero P, Chaves F, Luquero FJ. Estudio epidemiológico de portadores nasales de Staphylococcus aureus en centros de mayores. Rev Esp Quimioterap. 2007;20(3):339-45.

10. Martínez-Aguilar G, Ávalos-Mishaan A, Hulten K, Hammerman W, Mason EO, Kaplan SL. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis. 2004;23(8):701-6.

11. Palombarani S, Gardella N, Tuduri A, Figueroa S, Sly G, Corazza R, et al. Infecciones adquiridas en la comunidad por Staphylococcus aureus resistente a meticilina en un hospital de agudos. Rev Argent Microbiol. 2007;39(3):325-31.

12. Hernández IB, Toraño GT, González M, González I. Staphylococcus aureus resistente a la meticilina: detección de portadores entre niños hospitalizados y niños sanos de la comunidad. Rev Cubana Med Trop [Internet]. 2003 [citado 1ro. de octubre de 2011];55(3):153-61. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602003000300004&lng=es

13. Martínez-Aguilar G, Ávalos-Mishaan A, Hulten K, Hammerman W, Mason EO, Kaplan SL. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis. 2004;23(8):701-6.

14. Palombarani S, Gardella N, Tuduri A, Figueroa S, Sly G, Corazza R, et al. Infecciones adquiridas en la comunidad por Staphylococcus aureus resistente a meticilina en un hospital de agudos. Rev Argent Microbiol. 2007;39(3):325-31.

15. Eveillard M, Ernst C, Cuviller S. Prevalence of methicillin resistant Staphylococcus aureus carriage at the time of admission in two acute geriatric wards. J Hosp Infect. 2002;50(2):122-6.

16. Fridkin S, Hageman J, Morrison M, Thomson Sanza L, Como-Sabetti K, Jernigan J, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352(7):1436-44.

17. Palavecino E. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin Lab Med. 2004;24(2):403-18.

18. Shukla S. Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence. Clin Med Res. 2005;3(2):57-60.

19. Tenover F. Community-associated methicillin-resistant Staphylococcus aureus: it´s not just in communities anymore. Clin Microbiol News. 2006;28(30):33-6.

20. Sopena N, Sabriá M. Staphylococcus aureus resistente a la meticilina. Med Clin. 2002;118(8):671-5.

21. Centro para el Control Estatal de la calidad de los medicamentos. Anexo No. 09. Buenas prácticas para la fabricación de ingredientes farmacéuticos activos. Resolución No. 03/06 y Regulación No. 16-2006. Directrices sobre Buenas prácticas de fabricación de productos farmacéuticos. Ámbito regulador. Órgano oficial regulatorio. CECMED [Internet]. 2006 [citado 1ro. de octubre de 2011];6(Supl. Especial):1-16. Disponible en: http://www.cecmed.sld.cu/Docs/Pubs/AmbReg/2006/AmbReg_SENov_06.pdf

22. The United States Pharmacopeia. The National Formulary. USP30-NF25. Rockville: Mack Printing; 2007.

23. Rojas N, Coto O, Pazos V. Manual de Prácticas de Laboratorio de Microbiología Clínica. La Habana: Editorial Pueblo y Educación; 1987.

24. Liofilchem Diagnostici. Integral System Stafilococchi Ref.71718; Code F00713: Sistema colorimétrico per I´identificazione biochimica e I´antibiogramma degli stafilococchi. Roseto DA. Roma: Liofilchem Bacteriology Products; 2004.

25. Bantar C, Fernández CL, Smayevsky J, Bianchini H. Detection of oxacillin resistance by agar diffusion test at two temperatures in "borderline" Staphylococcus aureus. En: Programme and abstracts of the 18th International Congress of Chemotherapy, June 27-July 2, 1993. Stockholm, Sweden: APMIS; 1993. p. 88-118.

26. Van-Griethuysen A, Pouw M, Leeuwen N. Rapid slide latex agglutination test for detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol. 1999;37(11):2789-92.